Simultaneous degradation of 30 pharmaceuticals by anodic oxidation: Main intermediaries and by-products

Calzadilla, Wendy; Carolina Espinoza, L.; Silvia Diaz-Cruz, M.; Sunyer, Adria; Aranda, Mario; Pena-Farfal, Carlos; Salazar, Ricardo

Abstract

The anodic oxidation (AO) of 30 pharmaceuticals including antibiotics, hormones, antihistaminics, anti-inflammatories, antidepressants, antihypertensives, and antiulcer agents, in solutions containing different supporting electrolytes media (0.05 M Na2SO4, 0.05 M NaCl, and 0.05 M Na2SO4 + 0.05 M NaCl) at natural pH was studied. A boron-doped diamond (BDD) electrode and a stainless-steel electrode were used as anode and cathode, respectively, and three current densities of 6, 20, and 40 mA cm(-2) were applied. The results showed high mineralization rates, above 85%, in all the tested electrolytic media. 25 intermediaries produced during the electrooxidation were identified, depending on the supporting electrolyte together with the formation of carboxylic acids, NO3-, SO42- and NH4+ ions. The formation of intermediates in chloride medium produced an increase in absorbance. Finally, a real secondary effluent spiked with the 30 pharmaceuticals was treated by AO applying 6 mA cm(-2) at natural pH and without addition of supporting electrolyte, reaching c.a. 90% mineralization after 300 min, with an energy consumption of 18.95 kW h m(-3) equivalent to 2.90 USD m(-3). A degradation scheme for the mixture of emerging contaminants in both electrolytic media is proposed. Thus, the application of anodic oxidation generates a high concentration of hydroxyl radicals that favors the mineralization of the pharmaceuticals present in the spiked secondary effluent sample. (C) 2020 Elsevier Ltd. All rights reserved.

Más información

Título según WOS: Simultaneous degradation of 30 pharmaceuticals by anodic oxidation: Main intermediaries and by-products
Título de la Revista: CHEMOSPHERE
Volumen: 269
Editorial: PERGAMON-ELSEVIER SCIENCE LTD
Fecha de publicación: 2021
DOI:

10.1016/j.chemosphere.2020.128753

Notas: ISI